[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pediatric Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

July 2024 | 135 pages | ID: G0B9082F94CEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Pediatric Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Pediatric Drugs industry chain, the market status of Hospital (Allergy and Respiratory Drugs, Anti-Infectives), Clinic (Allergy and Respiratory Drugs, Anti-Infectives), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pediatric Drugs.

Regionally, the report analyzes the Pediatric Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pediatric Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Pediatric Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pediatric Drugs industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Allergy and Respiratory Drugs, Anti-Infectives).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pediatric Drugs market.

Regional Analysis: The report involves examining the Pediatric Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pediatric Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Pediatric Drugs:

Company Analysis: Report covers individual Pediatric Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pediatric Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Pediatric Drugs. It assesses the current state, advancements, and potential future developments in Pediatric Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pediatric Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Pediatric Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Allergy and Respiratory Drugs
  • Anti-Infectives
  • Cancer Therapies
  • Cardiovascular Drugs
  • Central Nervous System Drugs
  • Gastrointestinal Drugs
  • Hormone Drugs
  • Urological Drugs
Market segment by Application
  • Hospital
  • Clinic
  • Drugstore
Major players covered
  • Abbott Laboratories
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Colgate Oral Pharmaceuticals
  • Eli Lilly
  • Forest Laboratories
  • Genentech
  • GlaxoSmithKline
  • Johnson & Johnson
  • MedImmune
  • Merck
  • Novartis Pharmaceuticals
  • Novo Nordisk
  • Pfizer
  • Pharmacia
  • Roche
  • Schering-Plough
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pediatric Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pediatric Drugs, with price, sales, revenue and global market share of Pediatric Drugs from 2019 to 2024.

Chapter 3, the Pediatric Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pediatric Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pediatric Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pediatric Drugs.

Chapter 14 and 15, to describe Pediatric Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Pediatric Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Pediatric Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Allergy and Respiratory Drugs
  1.3.3 Anti-Infectives
  1.3.4 Cancer Therapies
  1.3.5 Cardiovascular Drugs
  1.3.6 Central Nervous System Drugs
  1.3.7 Gastrointestinal Drugs
  1.3.8 Hormone Drugs
  1.3.9 Urological Drugs
1.4 Market Analysis by Application
  1.4.1 Overview: Global Pediatric Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hospital
  1.4.3 Clinic
  1.4.4 Drugstore
1.5 Global Pediatric Drugs Market Size & Forecast
  1.5.1 Global Pediatric Drugs Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Pediatric Drugs Sales Quantity (2019-2030)
  1.5.3 Global Pediatric Drugs Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 Abbott Laboratories
  2.1.1 Abbott Laboratories Details
  2.1.2 Abbott Laboratories Major Business
  2.1.3 Abbott Laboratories Pediatric Drugs Product and Services
  2.1.4 Abbott Laboratories Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Abbott Laboratories Recent Developments/Updates
2.2 Bayer
  2.2.1 Bayer Details
  2.2.2 Bayer Major Business
  2.2.3 Bayer Pediatric Drugs Product and Services
  2.2.4 Bayer Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Bayer Recent Developments/Updates
2.3 Boehringer Ingelheim
  2.3.1 Boehringer Ingelheim Details
  2.3.2 Boehringer Ingelheim Major Business
  2.3.3 Boehringer Ingelheim Pediatric Drugs Product and Services
  2.3.4 Boehringer Ingelheim Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Bristol-Myers Squibb
  2.4.1 Bristol-Myers Squibb Details
  2.4.2 Bristol-Myers Squibb Major Business
  2.4.3 Bristol-Myers Squibb Pediatric Drugs Product and Services
  2.4.4 Bristol-Myers Squibb Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Colgate Oral Pharmaceuticals
  2.5.1 Colgate Oral Pharmaceuticals Details
  2.5.2 Colgate Oral Pharmaceuticals Major Business
  2.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Product and Services
  2.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Colgate Oral Pharmaceuticals Recent Developments/Updates
2.6 Eli Lilly
  2.6.1 Eli Lilly Details
  2.6.2 Eli Lilly Major Business
  2.6.3 Eli Lilly Pediatric Drugs Product and Services
  2.6.4 Eli Lilly Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Eli Lilly Recent Developments/Updates
2.7 Forest Laboratories
  2.7.1 Forest Laboratories Details
  2.7.2 Forest Laboratories Major Business
  2.7.3 Forest Laboratories Pediatric Drugs Product and Services
  2.7.4 Forest Laboratories Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Forest Laboratories Recent Developments/Updates
2.8 Genentech
  2.8.1 Genentech Details
  2.8.2 Genentech Major Business
  2.8.3 Genentech Pediatric Drugs Product and Services
  2.8.4 Genentech Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Genentech Recent Developments/Updates
2.9 GlaxoSmithKline
  2.9.1 GlaxoSmithKline Details
  2.9.2 GlaxoSmithKline Major Business
  2.9.3 GlaxoSmithKline Pediatric Drugs Product and Services
  2.9.4 GlaxoSmithKline Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 GlaxoSmithKline Recent Developments/Updates
2.10 Johnson & Johnson
  2.10.1 Johnson & Johnson Details
  2.10.2 Johnson & Johnson Major Business
  2.10.3 Johnson & Johnson Pediatric Drugs Product and Services
  2.10.4 Johnson & Johnson Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Johnson & Johnson Recent Developments/Updates
2.11 MedImmune
  2.11.1 MedImmune Details
  2.11.2 MedImmune Major Business
  2.11.3 MedImmune Pediatric Drugs Product and Services
  2.11.4 MedImmune Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 MedImmune Recent Developments/Updates
2.12 Merck
  2.12.1 Merck Details
  2.12.2 Merck Major Business
  2.12.3 Merck Pediatric Drugs Product and Services
  2.12.4 Merck Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Merck Recent Developments/Updates
2.13 Novartis Pharmaceuticals
  2.13.1 Novartis Pharmaceuticals Details
  2.13.2 Novartis Pharmaceuticals Major Business
  2.13.3 Novartis Pharmaceuticals Pediatric Drugs Product and Services
  2.13.4 Novartis Pharmaceuticals Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.13.5 Novartis Pharmaceuticals Recent Developments/Updates
2.14 Novo Nordisk
  2.14.1 Novo Nordisk Details
  2.14.2 Novo Nordisk Major Business
  2.14.3 Novo Nordisk Pediatric Drugs Product and Services
  2.14.4 Novo Nordisk Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.14.5 Novo Nordisk Recent Developments/Updates
2.15 Pfizer
  2.15.1 Pfizer Details
  2.15.2 Pfizer Major Business
  2.15.3 Pfizer Pediatric Drugs Product and Services
  2.15.4 Pfizer Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.15.5 Pfizer Recent Developments/Updates
2.16 Pharmacia
  2.16.1 Pharmacia Details
  2.16.2 Pharmacia Major Business
  2.16.3 Pharmacia Pediatric Drugs Product and Services
  2.16.4 Pharmacia Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.16.5 Pharmacia Recent Developments/Updates
2.17 Roche
  2.17.1 Roche Details
  2.17.2 Roche Major Business
  2.17.3 Roche Pediatric Drugs Product and Services
  2.17.4 Roche Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.17.5 Roche Recent Developments/Updates
2.18 Schering-Plough
  2.18.1 Schering-Plough Details
  2.18.2 Schering-Plough Major Business
  2.18.3 Schering-Plough Pediatric Drugs Product and Services
  2.18.4 Schering-Plough Pediatric Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.18.5 Schering-Plough Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: PEDIATRIC DRUGS BY MANUFACTURER

3.1 Global Pediatric Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pediatric Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Pediatric Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Pediatric Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Pediatric Drugs Manufacturer Market Share in 2023
  3.4.2 Top 6 Pediatric Drugs Manufacturer Market Share in 2023
3.5 Pediatric Drugs Market: Overall Company Footprint Analysis
  3.5.1 Pediatric Drugs Market: Region Footprint
  3.5.2 Pediatric Drugs Market: Company Product Type Footprint
  3.5.3 Pediatric Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Pediatric Drugs Market Size by Region
  4.1.1 Global Pediatric Drugs Sales Quantity by Region (2019-2030)
  4.1.2 Global Pediatric Drugs Consumption Value by Region (2019-2030)
  4.1.3 Global Pediatric Drugs Average Price by Region (2019-2030)
4.2 North America Pediatric Drugs Consumption Value (2019-2030)
4.3 Europe Pediatric Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Pediatric Drugs Consumption Value (2019-2030)
4.5 South America Pediatric Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Pediatric Drugs Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Pediatric Drugs Sales Quantity by Type (2019-2030)
5.2 Global Pediatric Drugs Consumption Value by Type (2019-2030)
5.3 Global Pediatric Drugs Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Pediatric Drugs Sales Quantity by Application (2019-2030)
6.2 Global Pediatric Drugs Consumption Value by Application (2019-2030)
6.3 Global Pediatric Drugs Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Pediatric Drugs Sales Quantity by Type (2019-2030)
7.2 North America Pediatric Drugs Sales Quantity by Application (2019-2030)
7.3 North America Pediatric Drugs Market Size by Country
  7.3.1 North America Pediatric Drugs Sales Quantity by Country (2019-2030)
  7.3.2 North America Pediatric Drugs Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Pediatric Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Pediatric Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Pediatric Drugs Market Size by Country
  8.3.1 Europe Pediatric Drugs Sales Quantity by Country (2019-2030)
  8.3.2 Europe Pediatric Drugs Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Pediatric Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pediatric Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pediatric Drugs Market Size by Region
  9.3.1 Asia-Pacific Pediatric Drugs Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Pediatric Drugs Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Pediatric Drugs Sales Quantity by Type (2019-2030)
10.2 South America Pediatric Drugs Sales Quantity by Application (2019-2030)
10.3 South America Pediatric Drugs Market Size by Country
  10.3.1 South America Pediatric Drugs Sales Quantity by Country (2019-2030)
  10.3.2 South America Pediatric Drugs Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Pediatric Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pediatric Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pediatric Drugs Market Size by Country
  11.3.1 Middle East & Africa Pediatric Drugs Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Pediatric Drugs Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Pediatric Drugs Market Drivers
12.2 Pediatric Drugs Market Restraints
12.3 Pediatric Drugs Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Pediatric Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pediatric Drugs
13.3 Pediatric Drugs Production Process
13.4 Pediatric Drugs Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Pediatric Drugs Typical Distributors
14.3 Pediatric Drugs Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Pediatric Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pediatric Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Pediatric Drugs Product and Services
Table 6. Abbott Laboratories Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Abbott Laboratories Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Pediatric Drugs Product and Services
Table 11. Bayer Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bayer Recent Developments/Updates
Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim Major Business
Table 15. Boehringer Ingelheim Pediatric Drugs Product and Services
Table 16. Boehringer Ingelheim Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Boehringer Ingelheim Recent Developments/Updates
Table 18. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Pediatric Drugs Product and Services
Table 21. Bristol-Myers Squibb Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bristol-Myers Squibb Recent Developments/Updates
Table 23. Colgate Oral Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Colgate Oral Pharmaceuticals Major Business
Table 25. Colgate Oral Pharmaceuticals Pediatric Drugs Product and Services
Table 26. Colgate Oral Pharmaceuticals Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Colgate Oral Pharmaceuticals Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Pediatric Drugs Product and Services
Table 31. Eli Lilly Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Forest Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. Forest Laboratories Major Business
Table 35. Forest Laboratories Pediatric Drugs Product and Services
Table 36. Forest Laboratories Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Forest Laboratories Recent Developments/Updates
Table 38. Genentech Basic Information, Manufacturing Base and Competitors
Table 39. Genentech Major Business
Table 40. Genentech Pediatric Drugs Product and Services
Table 41. Genentech Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Genentech Recent Developments/Updates
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline Pediatric Drugs Product and Services
Table 46. GlaxoSmithKline Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. GlaxoSmithKline Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson Pediatric Drugs Product and Services
Table 51. Johnson & Johnson Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. MedImmune Basic Information, Manufacturing Base and Competitors
Table 54. MedImmune Major Business
Table 55. MedImmune Pediatric Drugs Product and Services
Table 56. MedImmune Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. MedImmune Recent Developments/Updates
Table 58. Merck Basic Information, Manufacturing Base and Competitors
Table 59. Merck Major Business
Table 60. Merck Pediatric Drugs Product and Services
Table 61. Merck Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Merck Recent Developments/Updates
Table 63. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Novartis Pharmaceuticals Major Business
Table 65. Novartis Pharmaceuticals Pediatric Drugs Product and Services
Table 66. Novartis Pharmaceuticals Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Novartis Pharmaceuticals Recent Developments/Updates
Table 68. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 69. Novo Nordisk Major Business
Table 70. Novo Nordisk Pediatric Drugs Product and Services
Table 71. Novo Nordisk Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Novo Nordisk Recent Developments/Updates
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Pediatric Drugs Product and Services
Table 76. Pfizer Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pharmacia Basic Information, Manufacturing Base and Competitors
Table 79. Pharmacia Major Business
Table 80. Pharmacia Pediatric Drugs Product and Services
Table 81. Pharmacia Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Pharmacia Recent Developments/Updates
Table 83. Roche Basic Information, Manufacturing Base and Competitors
Table 84. Roche Major Business
Table 85. Roche Pediatric Drugs Product and Services
Table 86. Roche Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Roche Recent Developments/Updates
Table 88. Schering-Plough Basic Information, Manufacturing Base and Competitors
Table 89. Schering-Plough Major Business
Table 90. Schering-Plough Pediatric Drugs Product and Services
Table 91. Schering-Plough Pediatric Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Schering-Plough Recent Developments/Updates
Table 93. Global Pediatric Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 94. Global Pediatric Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 95. Global Pediatric Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 96. Market Position of Manufacturers in Pediatric Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 97. Head Office and Pediatric Drugs Production Site of Key Manufacturer
Table 98. Pediatric Drugs Market: Company Product Type Footprint
Table 99. Pediatric Drugs Market: Company Product Application Footprint
Table 100. Pediatric Drugs New Market Entrants and Barriers to Market Entry
Table 101. Pediatric Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Pediatric Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 103. Global Pediatric Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 104. Global Pediatric Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Global Pediatric Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 106. Global Pediatric Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 107. Global Pediatric Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 108. Global Pediatric Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Global Pediatric Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Global Pediatric Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 111. Global Pediatric Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 112. Global Pediatric Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 113. Global Pediatric Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 114. Global Pediatric Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Global Pediatric Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Global Pediatric Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 117. Global Pediatric Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 118. Global Pediatric Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 119. Global Pediatric Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 120. North America Pediatric Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 121. North America Pediatric Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 122. North America Pediatric Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 123. North America Pediatric Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 124. North America Pediatric Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 125. North America Pediatric Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 126. North America Pediatric Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 127. North America Pediatric Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Europe Pediatric Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 129. Europe Pediatric Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 130. Europe Pediatric Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 131. Europe Pediatric Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 132. Europe Pediatric Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 133. Europe Pediatric Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 134. Europe Pediatric Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Pediatric Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Pediatric Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 137. Asia-Pacific Pediatric Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 138. Asia-Pacific Pediatric Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 139. Asia-Pacific Pediatric Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 140. Asia-Pacific Pediatric Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 141. Asia-Pacific Pediatric Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 142. Asia-Pacific Pediatric Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 143. Asia-Pacific Pediatric Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 144. South America Pediatric Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 145. South America Pediatric Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 146. South America Pediatric Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 147. South America Pediatric Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 148. South America Pediatric Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 149. South America Pediatric Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 150. South America Pediatric Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 151. South America Pediatric Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 152. Middle East & Africa Pediatric Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 153. Middle East & Africa Pediatric Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 154. Middle East & Africa Pediatric Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 155. Middle East & Africa Pediatric Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 156. Middle East & Africa Pediatric Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 157. Middle East & Africa Pediatric Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 158. Middle East & Africa Pediatric Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 159. Middle East & Africa Pediatric Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 160. Pediatric Drugs Raw Material
Table 161. Key Manufacturers of Pediatric Drugs Raw Materials
Table 162. Pediatric Drugs Typical Distributors
Table 163. Pediatric Drugs Typical Customers

LIST OF FIGURES

Figure 1. Pediatric Drugs Picture
Figure 2. Global Pediatric Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pediatric Drugs Consumption Value Market Share by Type in 2023
Figure 4. Allergy and Respiratory Drugs Examples
Figure 5. Anti-Infectives Examples
Figure 6. Cancer Therapies Examples
Figure 7. Cardiovascular Drugs Examples
Figure 8. Central Nervous System Drugs Examples
Figure 9. Gastrointestinal Drugs Examples
Figure 10. Hormone Drugs Examples
Figure 11. Urological Drugs Examples
Figure 12. Global Pediatric Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 13. Global Pediatric Drugs Consumption Value Market Share by Application in 2023
Figure 14. Hospital Examples
Figure 15. Clinic Examples
Figure 16. Drugstore Examples
Figure 17. Global Pediatric Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Pediatric Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Pediatric Drugs Sales Quantity (2019-2030) & (K Units)
Figure 20. Global Pediatric Drugs Average Price (2019-2030) & (USD/Unit)
Figure 21. Global Pediatric Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Pediatric Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Pediatric Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Pediatric Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Pediatric Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Pediatric Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Pediatric Drugs Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Pediatric Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Pediatric Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Pediatric Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Pediatric Drugs Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Pediatric Drugs Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Pediatric Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Pediatric Drugs Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Pediatric Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 36. Global Pediatric Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Pediatric Drugs Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Pediatric Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 39. North America Pediatric Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Pediatric Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Pediatric Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Pediatric Drugs Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Pediatric Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Pediatric Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Pediatric Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Pediatric Drugs Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Pediatric Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Pediatric Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Pediatric Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Pediatric Drugs Consumption Value Market Share by Region (2019-2030)
Figure 59. China Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Pediatric Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Pediatric Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Pediatric Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Pediatric Drugs Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Pediatric Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Pediatric Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Pediatric Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Pediatric Drugs Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Pediatric Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Pediatric Drugs Market Drivers
Figure 80. Pediatric Drugs Market Restraints
Figure 81. Pediatric Drugs Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Pediatric Drugs in 2023
Figure 84. Manufacturing Process Analysis of Pediatric Drugs
Figure 85. Pediatric Drugs Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source


More Publications